Viibryd Lawsuits are a Growing Possibility SSRI and Viibryd Lawsuits
Viibryd (vilazodone) is a unique antidepressant because it acts as both a selective serotonin reputake inhibitor (SSRI) and 5HT1A receptor partial agonist. The SSRI aspect of Viibryd works to elevate the brain’s serotonin levels, while the 5HT1A receptor partial agonist affects the alleles of the HT transporter gene.
Concerns are building for Viibryd because similar antidepressants categorized as SSRIs such as Prozac have been linked with adverse side effects. The SSRI drugs’ side effects are particularly dangerous to unborn children who are exposed to the SSRI chemicals during fetal development – potentially causing congenital birth defects. As a result, individuals affected by SSRI birth defects are seeking retribution from pharmaceutical manufacturers through SSRI lawsuits.
Concerns Growing for Potential Viibryd Birth Defects
The U.S. Food and Drug Administration (FDA) approved Viibryd in 2011; there have been no reported incidences of birth defects connected with Viibryd. However, since Viibryd is similar to other antidepressants that have been linked congenital birth defects worries exist that Viibryd may have the same side effects.
Other SSRI antidepressants have been linked with congenital birth defects such as abdominal defects, cranial defects, heart defects, and persistent pulmonary hypertension of newborns (PPHN).
The potential heart defects include the following:
- Atrial septal defects (ASD)
- Ventricular septal defects (VSD)
- Tetrology of fallot (ToF)
- Hypoplastic left heart syndrome (HLHS)
- Transposition of the great arteries (TGA or TOGA)
- Patent ductus arteriosus (PDA)
- Total anomalous pulmonary venous return (TAPVR)
- Double outlet right ventricle (DORV)
- Coarctation of the aorta (CoA)
PPHN is a condition that causes the pressure in the lungs’ blood vessels to remain low after birth resulting in high blood pressure in the heart. As a result, the body’s bloodstream lacks a sufficient amount of oxygen, which leads to other health complications such as difficulty breathing.
Starting a SSRI or Viibryd Lawsuit
As the risk for a potential congenital birth defect caused by Viibryd grows, so do the number of Viibryd lawyers. If you or a loved one has taken an SSRI antidepressant during pregnancy and given birth to a newborn suffering from a birth defect, you should contact one of Chaffin Luhana LLP’s Upstene drug lawyers at 1-888-480-1123 today for a free and confidential SSRI or Viibryd lawsuit case review. You may be entitled to compensation, and the lawyers at Chaffin Luhana are prepared to help.